Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-75
SponsorUniversity of Colorado, Denver

About this trial

The goal of this interventional study is to create and test a comprehensive and low burden text message program within existing Community Health Centers (CHC) electronic records system to encourage patients to complete at home colorectal cancer (CRC) screening and to make sure they get follow-up care if their results are abnormal.

First, the investigators will learn from clinic staff and patients what their needs and preferences are in terms of use of technology. This information will be used to design the text messages program.

* Clinic patients will participate in focus groups * Clinic staff will participate in interviews

Second, the investigators will test a series of different message versions in two batches (experiments):

* Clinic patients with orders for an at-home colorectal cancer screening kit will receive the different message versions. * In the first batch, the messages that get the most engagement from patients will be selected to be used in the second experiment. * In the second batch, the investigators will test which messages lead to the most colorectal cancer screening completion. * This will be rolled-out within the clinics existing electronic record system. The study team will not receive any information that will identify individual patients.

Lastly, the investigators will check again with clinic staff to learn how the program performed, and what would be needed to continue using the text message program in the long run.

-Clinic staff will participate in interviews and surveys.

Eligibility criteria

Qualifiers

Adults 45-75 years old

Receive care in partner CHCs

Are of average risk for colorectal cancer

Received a stool-based testing order at their CHC

Disqualifiers

Personal or family history of CRC or colorectal polyps

History of inflammatory bowel disease

Heritable conditions that put them at above average risk for colorectal cancer (e.g., familial adenomatous polyposis)

Adult employees of participating CHCs

Trial design

Treatments tested in this trial

  • Personalized Text Message
  • Screening Concerns Text Message
  • Message Framing Text Message
  • Autonomy Support Outreach
  • Impediments Support Outreach
  • Live Support Outreach
  • Data Reporting and Visualization System Tools

Treatment groups

7,220 Participants
are divided into 16 treatment groups

16

Treatment groups

See each treatment group below.

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Cancer Institute (NCI)

Collaborator

Massachusetts League of Community Health Centers

Collaborator

Dana-Farber Cancer Institute

Collaborator

University of Texas Southwestern Medical Center

Collaborator

Massachusetts General Hospital

Collaborator